Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The drug also showed promise for colorectal and other cancers, but it might work better in combination regimens.
The premier platform not only for the presentation of new science, but also for unique networking opportunities.
Quitting smoking even within two years before a lung cancer diagnosis improves survival.
A Phase 1 study on customized immunotherapy shows promise for people with lung cancer.
Sanda Cohen, 63, a retired physician in Louisville, Kentucky, has lived with Stage IV lung cancer a year longer than she was told she would.
Current recommendations don’t accurately reflect the community most affected by this disease.
The targeted therapy shrank tumors in more than half of people with previously treated non-small-cell lung cancer.
Smoking is on the decline, and Black lung cancer rates are the better for it.
Scientists discover a single gene’s role in drug resistance and look for ways to re-sensitize tumors to chemotherapy.
In recent years, deaths from non-small cell lung cancer (NSCLC) have decreased even faster than the decrease in NSCLC incidence.
Elevated levels of a protein called RUNX2 in human lung tumors predict a worse prognosis.
Delays in screening, diagnosis and treatment could lead to poorer outcomes.
Draft recommendation would ensure more women and Black people meet the screening criteria.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.